Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults

Clinical trial NCT02377401 · COMPLETED

Trial details

NCT number: NCT02377401
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2015-04-28
Primary completion: 2015-06-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.